Home
About us
Corporate Profile
Our Mission
Our Vision
BiBo team
Services
Mammalian cell culture platform
Microbial fermentation platform
Gene therapy（AAV）
GMP Manufacture
Formulation, F&F
Innovative Technology Platform
Facilities
BiBo R&D Centers (Boston, Shanghai)
BiBo P01 (Shanghai Zhangjiang)
BiBo P02 (Shanghai Lingang)
BiBo P03 (Shanghai Lingang)
Customized production lines
News
Company news
Industy news
Contact
Choose BiBo
Talent recruitment
Contact us
CN
Company news
Industy news
Novartis plots $300M investment to grow its biologics manufacturing and development operations
2022-11-23
Fujifilm: Investing $2 billion to expand CDMO project
2022-11-07
The fourth factory of Samsung Biologics was completed in South Korea,The total investment exceeds 2 trillion won
2022-11-07
